We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.
In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183
Nordic Capital sells, then re-buys Nycomed Holding
21 Apr 2005
Executive Summary
Investment bank Nordic Capital has entered into a definitive agreement to sell Nycomed Holding AS (the old Nycomed Pharma; pharmaceutical in-licensing and development) to a new investment company owned by CSFB Private Equity, Blackstone Capital Partners, and NIB Capital Private Equity. The purchase price is approximately $1.1bn, roughly 2 times Nycomed's 2001 sales, and is split evenly between debt and equity.
Deal Industry
Pharmaceuticals
Deal Status
Final
Deal Type
Acquisition
Buy-out
Full Acquisition
Payment Includes Cash
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?